Ann Belmans

6.5k total citations · 1 hit paper
72 papers, 2.6k citations indexed

About

Ann Belmans is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Ann Belmans has authored 72 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 29 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Ann Belmans's work include Cardiac Valve Diseases and Treatments (11 papers), Coronary Interventions and Diagnostics (10 papers) and Acute Myocardial Infarction Research (8 papers). Ann Belmans is often cited by papers focused on Cardiac Valve Diseases and Treatments (11 papers), Coronary Interventions and Diagnostics (10 papers) and Acute Myocardial Infarction Research (8 papers). Ann Belmans collaborates with scholars based in Belgium, Netherlands and United States. Ann Belmans's co-authors include Philip Moons, Werner Budts, Marc Gewillig, Frans Van de Werf, Peter Sinnaeve, Stefan Janssens, Walter Desmet, Christophe Dubois, Jennifer Adgey and Pierre Carli and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Ann Belmans

67 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Temporal Trends in Survival to Adulthood Among Patients Born With Congenital Heart Disease From 1970 to 1992 in Belgium

2010 506 citations Ann Belmans et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann Belmans Belgium	24	1.1k	1.0k	771	424	379	72	2.6k
Eduardo A. Pérez United States	28	1.6k 1.4×	237 0.2×	510 0.7×	345 0.8×	1.2k 3.2×	164	3.4k
René Warschkow Switzerland	32	2.2k 1.9×	508 0.5×	215 0.3×	131 0.3×	969 2.6×	134	3.3k
C.J.H.M. van Laarhoven Netherlands	31	2.3k 2.0×	387 0.4×	449 0.6×	189 0.4×	501 1.3×	96	2.9k
Theresa M. Boley United States	27	1.5k 1.3×	999 1.0×	487 0.6×	155 0.4×	1.3k 3.5×	81	2.8k
Juan E. Sola United States	30	1.9k 1.6×	113 0.1×	413 0.5×	500 1.2×	820 2.2×	210	3.3k
Joseph Mamazza Canada	34	2.1k 1.9×	380 0.4×	92 0.1×	350 0.8×	872 2.3×	86	2.8k
Riccardo Rosati Italy	35	2.9k 2.5×	436 0.4×	145 0.2×	87 0.2×	1.4k 3.7×	214	4.1k
Manish Parikh United States	33	2.7k 2.3×	859 0.8×	95 0.1×	113 0.3×	728 1.9×	117	3.7k
Donald L. van der Peet Netherlands	39	5.2k 4.6×	630 0.6×	269 0.3×	581 1.4×	3.2k 8.5×	148	6.1k
Robert L. Thurer United States	27	1.3k 1.1×	927 0.9×	291 0.4×	179 0.4×	845 2.2×	77	2.9k

Countries citing papers authored by Ann Belmans

Since Specialization

Citations

This map shows the geographic impact of Ann Belmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Belmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Belmans more than expected).

Fields of papers citing papers by Ann Belmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Belmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Belmans. The network helps show where Ann Belmans may publish in the future.

Co-authorship network of co-authors of Ann Belmans

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Belmans. A scholar is included among the top collaborators of Ann Belmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Belmans. Ann Belmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peetermans, Marijke, Philippe Meersseman, Alexander Wilmer, et al.. (2025). Outcomes of transplant recipients on ECMO for COVID-19 respiratory failure: an ELSO registry study. Critical Care. 29(1). 404–404.

Decraecker, Lisse, Danny De Looze, David P. Hirsch, et al.. (2024). 238 TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL. Gastroenterology. 166(5). S–53. 1 indexed citations

Pokreisz, Péter, Piet Claus, Andrea Casazza, et al.. (2024). Recombinant human placental growth factor-2 in post-infarction left ventricular dysfunction: a randomized, placebo-controlled, preclinical study. Basic Research in Cardiology. 119(5). 795–806. 1 indexed citations

Slambrouck, Jan Van, Herbert Decaluwé, Xin Jin, et al.. (2024). Comparing right- versus left-first implantation in off-pump sequential double-lung transplantation: an observational cohort study. European Journal of Cardio-Thoracic Surgery. 66(3). 3 indexed citations

Decraecker, Lisse, Danny De Looze, David P. Hirsch, et al.. (2024). Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial. Gut. 73(3). 459–469. 15 indexed citations

Maury, Eléonore, Ann Belmans, Kris Bogaerts, Stefaan Vancayzeele, & Mieke Jansen. (2024). Real-life effectiveness of sacubitril/valsartan in older Belgians with heart failure, reduced ejection fraction and most severe symptoms. Scientific Reports. 14(1). 13512–13512. 1 indexed citations

Boeckxstaens, Guy E., Ann Belmans, Vito Annese, et al.. (2023). 10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy. Gut. 73(4). 582–589. 5 indexed citations

Jaeghere, Emiel A. De, Sandra Tuyaerts, Ann Belmans, et al.. (2022). 2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer: the PRIMMO phase II trial. International Journal of Gynecological Cancer. 32. A187–A188.

Ockerman, Anna, Maarten Vanhaverbeke, Thomas Vanassche, et al.. (2021). Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial. PLoS Medicine. 18(5). e1003601–e1003601. 12 indexed citations

10.

Ameloot, Koen, C. De Deyne, Ward Eertmans, et al.. (2019). Early goal-directed haemodynamic optimization of cerebral oxygenation in comatose survivors after cardiac arrest: the Neuroprotect post-cardiac arrest trial. European Heart Journal. 40(22). 1804–1814. 123 indexed citations

11.

Vandenberk, Bert, et al.. (2017). Introducing ICD-resistant mortality as an end point to evaluate the clinical efficacy of an implantable cardioverter-defibrillator in ischaemic cardiomyopathy. Acta cardiologica. Supplementum. 73(1). 19–27. 1 indexed citations

12.

Teeuwen, Koen, Johan Bennett, Christophe Dubois, et al.. (2017). Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial. EuroIntervention. 13(5). e522–e530. 12 indexed citations

13.

Moonen, An, Vito Annese, Ann Belmans, et al.. (2015). Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 65(5). 732–739. 252 indexed citations

14.

Smeets, Ann, Ann Belmans, Hans Wildiers, et al.. (2013). Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer. SpringerPlus. 2(1). 480–480. 11 indexed citations

15.

Herbots, Lieven, Jan D’hooge, Elif Eroğlu, et al.. (2008). Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study. European Heart Journal. 30(6). 662–670. 77 indexed citations

16.

Janssens, Stefan, Jan Bogaert, Christophe Dubois, et al.. (2006). Long-term safety and efficacy of autologous bone marrow-derived stem cell transfer after acute myocardial infarction. Circulation. 114(18). 515–515. 5 indexed citations

17.

Janssens, Stefan, Jan Bogaert, Koen Theunissen, et al.. (2005). Transplantation of autologous bone marrow-derived stem cells in patients with ST-segment elevation myocardial infarction. Circulation. 112(17).

18.

Vrijens, Bernard, Ann Belmans, K. E. Matthys, Erik de Klerk, & Emmanuel Lesaffre. (2005). Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once‐daily atorvastatin. Pharmacoepidemiology and Drug Safety. 15(2). 115–121. 68 indexed citations

19.

Sinnaeve, Peter, John H. Alexander, Ann Belmans, et al.. (2003). One-year follow-up of the ASSENT-2 trial: A double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction. American Heart Journal. 146(1). 27–32. 31 indexed citations

20.

Dubois, Christophe, Ann Belmans, Christopher B. Granger, et al.. (2003). Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab. Journal of the American College of Cardiology. 42(7). 1178–1185. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact